BioAge Labs Inc risk profile
77 Stretched several inputs deteriorating together
Measured 21 October 2026 from BIOA's filed statements. Recomputed nightly.
77 (Stretched), driven by Cash conversion at 100, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 79 | Stretched | Volatile | One-year price volatility — 109.8% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 100 | Acute | Stable | Capital spending against operating cash — -0.01x |
| Leverage and coverage | 35 | Normal | Stable | Interest cover — -114.34x |
| Competitive position | 69 | Stretched | Stable | Operating-margin gap against peers — -1,028.1 percentage points |
| Concentration | 100 | Acute | Stable | Customer concentration — 10,000 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.